- 
        Taxonomy & unit
      
 
      - 
        us-gaap: USD
      
 
    
    
      
- 
        Description
      
 
      - 
        The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
      
 
    
    
      - 
        Summary
      
 
      - 
        Marker Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Marker Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$4.02M, a 83.1% decline year-over-year.
 - Marker Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$14.6M, a 40.9% decline year-over-year.
 - Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$10.7M, a 30.3% decline from 2023.
 - Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.24M, a 72.5% increase from 2022.
 - Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.9M, a 28.5% increase from 2021.
 
       
     
   
    
  Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
  
  
  Net Income (Loss) Attributable to Parent, Annual (USD)
  
    
  Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)